Literature DB >> 23286733

Evidence of oral translocation of anionic G6.5 dendrimers in mice.

Giridhar Thiagarajan1, Shraddha Sadekar, Khaled Greish, Abhijit Ray, Hamidreza Ghandehari.   

Abstract

Development of carrier systems to improve oral bioavailability and target drugs to specific sites continues to be an unmet need. The goal of this study was to evaluate the potential of anionic generation (G) 6.5 poly(amido amine) (PAMAM) dendrimers in oral drug delivery by assessing their in vivo oral translocation. G6.5-COOH dendrimers were characterized for their physiochemical characteristics and acute oral toxicity was assessed in CD-1 mice. The dendrimers were labeled with (125)I and their stability evaluated. Oral bioavailability was assessed in the same mouse model. Investigation of the radioactivity profile in plasma revealed presence of both large and small molecular weight compounds. Detailed area under the curve analysis suggests an effective 9.4% bioavailability of radiolabeled marker associated with G6.5-COOH. Results reported here suggest the potential of dendrimers in permeating gastrointestinal barriers in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23286733      PMCID: PMC3715149          DOI: 10.1021/mp300436c

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  46 in total

Review 1.  Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.

Authors:  Monjed Shakweh; Gilles Ponchel; Elias Fattal
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 2.  Novel approaches for oral delivery of macromolecules.

Authors:  A Fasano
Journal:  J Pharm Sci       Date:  1998-11       Impact factor: 3.534

3.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

Authors:  Thommey P Thomas; Sascha N Goonewardena; Istvan J Majoros; Alina Kotlyar; Zhengyi Cao; Pascale R Leroueil; James R Baker
Journal:  Arthritis Rheum       Date:  2011-09

4.  Small intestine transit time in the normal small bowel study.

Authors:  S K Kim
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-11

5.  Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma.

Authors:  Brent B Ward; Thomas Dunham; Istvan J Majoros; James R Baker
Journal:  J Oral Maxillofac Surg       Date:  2011-09       Impact factor: 1.895

Review 6.  Water soluble polymers in tumor targeted delivery.

Authors:  J Kopecek; P Kopecková; T Minko; Z R Lu; C M Peterson
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

7.  In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation.

Authors:  R Inapagolla; B Raja Guru; Y E Kurtoglu; X Gao; M Lieh-Lai; D J P Bassett; R M Kannan
Journal:  Int J Pharm       Date:  2010-08-19       Impact factor: 5.875

8.  Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.

Authors:  Chie Kojima; Celeste Regino; Yasuhito Umeda; Hisataka Kobayashi; Kenji Kono
Journal:  Int J Pharm       Date:  2009-09-15       Impact factor: 5.875

Review 9.  Therapeutic and diagnostic applications of dendrimers for cancer treatment.

Authors:  Jesse B Wolinsky; Mark W Grinstaff
Journal:  Adv Drug Deliv Rev       Date:  2008-03-04       Impact factor: 15.470

Review 10.  Dendrimers as versatile platform in drug delivery applications.

Authors:  Sonke Svenson
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

View more
  7 in total

Review 1.  Poly(amido amine) dendrimers in oral delivery.

Authors:  Venkata K Yellepeddi; Hamidreza Ghandehari
Journal:  Tissue Barriers       Date:  2016-04-06

2.  Charge affects the oral toxicity of poly(amidoamine) dendrimers.

Authors:  Giridhar Thiagarajan; Khaled Greish; Hamidreza Ghandehari
Journal:  Eur J Pharm Biopharm       Date:  2013-02-16       Impact factor: 5.571

3.  Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation.

Authors:  Venkata K Yellepeddi; Raziye Mohammadpour; Siva P Kambhampati; Casey Sayre; Manoj K Mishra; Rangaramanujam M Kannan; Hamidreza Ghandehari
Journal:  Int J Pharm       Date:  2018-04-20       Impact factor: 5.875

Review 4.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

5.  Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.

Authors:  Fan Zhang; Elizabeth Nance; Zhi Zhang; Venkatasai Jasty; Siva P Kambhampati; Manoj K Mishra; Irina Burd; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2016-07-01       Impact factor: 9.776

Review 6.  Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.

Authors:  Pratap C Naha; Sourav P Mukherjee; Hugh J Byrne
Journal:  Int J Environ Res Public Health       Date:  2018-02-14       Impact factor: 3.390

7.  Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.

Authors:  Dallin Hubbard; Hamidreza Ghandehari; David J Brayden
Journal:  Biomacromolecules       Date:  2014-07-03       Impact factor: 6.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.